Others found lower D2R mRNA expression levels in overt or subclinical CD adenomas vs. silent ACTH-producing tumors (11), as well as higher expression levels in noninvasive microadenomas vs. higher-grade adenomas (12). This evidence concerns the gene POMC and adenoma.